# Natural Berry Extract Treatment of Hemangiomas

> **NCT04020419** · EARLY_PHASE1 · TERMINATED · sponsor: **Gayle Gordillo** · enrollment: 12 (actual)

## Conditions studied

- Hemangioma

## Interventions

- **DRUG:** PediaBerry

## Key facts

- **NCT ID:** NCT04020419
- **Lead sponsor:** Gayle Gordillo
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-12-01
- **Primary completion:** 2023-05-24
- **Final completion:** 2023-05-24
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Study ending early due to program transferring to another site.
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04020419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04020419, "Natural Berry Extract Treatment of Hemangiomas". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04020419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*